跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ESOMEPRAZOLE
Authorized
STANDARD
ESOMEPRAZOLE
Ethypharm Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5a5a5c195a7b659b
Company
Ethypharm Inc
Type
Standard
Approval Details
Approval Id
5a5a5c195a7b659b
Drug Approval Canada Name
ESOMEPRAZOLE
Product Name
ESOMEPRAZOLE
Status
Approved
Status Date
2016-10-03
Din
02417499
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC05 ESOMEPRAZOLE
Atc Name
a 02 bc 05
Aig Number
0145162002
Company Name
Ethypharm Inc
Company Address
SUITE 1500, 1200 Avenue Mcgill College, Montreal, Quebec, Canada, H3B 4G7
Company Detail Path
/organization/ethypharm-inc
Company Information
Pharmaceutical Company Name
Ethypharm Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
1000 rue de la Gauchetière O bureau 2400
Active Ingredients
ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM DIHYDRATE)
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5a5a5c195a7b659b
Type
Standard
Back to Health Canada Approvals